IOT Share Price | Innovotech, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Innovotech, Inc. with Similar Stocks

Aion Therapeutic, Inc.Jack Nathan Medical Corp.UniDoc Health Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared positive results in Sep'2024 after 4 consecutive negative quarters

NET SALES(HY) At CAD 2.25 MM has Grown at 169.81%
PRE-TAX PROFIT(Q) At CAD 0.09 MM has Grown at 3,576.2%
NET PROFIT(Q) At CAD 0.09 MM has Grown at 12,226.19%

With ROE of 3.68%, it has a fair valuation with a 3.96 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 11 Million (Micro Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.37

Return on Equity

3.68%

Price to Book

3.96

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Sep 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-36.0%

6 Months

-23.81%

1 Year

14.29%

2 Years

113.33%

3 Years

18.52%

4 Years

-17.95%

5 Years

-3.03%

Innovotech, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

33.80%

EBIT Growth (5y)

4.23%

EBIT to Interest (avg)

-0.04

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

1.24

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.64%

ROE (avg)

10.24%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.96

EV to EBIT

9.88

EV to EBITDA

9.88

EV to Capital Employed

5.68

EV to Sales

2.22

PEG Ratio

0.09

Dividend Yield

ROCE (Latest)

13.27%

ROE (Latest)

3.68%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 30.00% vs -16.67% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 150.00% vs -300.00% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.30",
          "val2": "1.00",
          "chgp": "30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.20",
          "val2": "-0.20",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "-0.20",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.10%",
          "val2": "-214.30%",
          "chgp": "33.54%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 83.33% vs 9.09% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 200.00% vs -100.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.20",
          "val2": "1.20",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.30",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.20",
          "val2": "-0.20",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-80.00%",
          "val2": "-356.10%",
          "chgp": "27.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

1.30

1.00

30.00%

Operating Profit (PBDIT) excl Other Income

0.20

-0.20

200.00%

Interest

0.00

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

0.10

-0.20

150.00%

Operating Profit Margin (Excl OI)

121.10%

-214.30%

33.54%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 30.00% vs -16.67% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 150.00% vs -300.00% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2.20

1.20

83.33%

Operating Profit (PBDIT) excl Other Income

-0.10

-0.30

66.67%

Interest

0.00

Exceptional Items

0.20

Consolidate Net Profit

0.20

-0.20

200.00%

Operating Profit Margin (Excl OI)

-80.00%

-356.10%

27.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 83.33% vs 9.09% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 200.00% vs -100.00% in Dec 2023

All Annual Results

Company CV

About Innovotech, Inc.

Innovotech, Inc.

Pharmaceuticals & Biotechnology

Innovotech Inc is a Canada-based company, which operates in the field of biofilm product development, practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company's current products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbal biofilms for research purposes. The Company's products are effective against such diseases as Powdery Mildew on lettuce, White Mould on beans, Bacterial Spot on tomatoes and Fire Blight on apples. The Company's products include InnovoSIL, MBEC Assay Agress and AgreGuard.

Company Coordinates

Company Details

2011 94 St NW Suite 101 , EDMONTON AB : T6N 1H1

Tel: 1 780 4480585

http://www.innovotech.ca/

Registrar Details